Predictive Effect of Atypical Right Bundle-Branch Block on In-Hospital Sudden Cardiac Death and Cardiac Rupture and

Tiangui Yang1, Jie Chen1, Xi Fu1

  • 1Department of Cardiology Shengjing Hospital of China Medical University Shenyang Liaoning China.

Insights

Atypical right bundle-branch blocks (ARBBB) predict higher risks of in-hospital sudden cardiac death and cardiac rupture in acute myocardial infarction patients. This finding highlights ARBBB as a crucial indicator for adverse outcomes following percutaneous coronary intervention.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Interventional Cardiology

Background:

  • Atypical right bundle-branch block (ARBBB) is a less understood electrocardiographic finding.
  • Its prognostic significance in acute myocardial infarction (AMI) patients undergoing percutaneous coronary intervention (PCI) requires further elucidation.
  • Understanding ARBBB's impact on sudden cardiac death (SCD) and cardiac rupture (CR) is critical for patient management.

Purpose of the Study:

  • To investigate the predictive value of ARBBB for in-hospital SCD, CR, and long-term prognosis.
  • To compare outcomes among patients with ARBBB, typical right BBB, left BBB, and no BBB.
  • To assess ARBBB's role in predicting major adverse cardiovascular and cerebrovascular events (MACCE) within two years.

Main Methods:

  • Retrospective study including 13,886 patients with first-episode AMI undergoing drug-eluting stent PCI.
  • Patients were categorized into four groups: ARBBB (n=348), typical right BBB (n=374), left BBB (n=366), and non-BBB (n=12,798).
  • Primary endpoints were in-hospital SCD and CR; secondary endpoint was 2-year MACCE.

Main Results:

  • ARBBB group showed significantly higher incidences of in-hospital SCD (10.6%) and CR (5.7%) compared to other groups (P<0.001).
  • ARBBB was a significant predictor of in-hospital SCD (HR, 2.45) and CR (HR, 3.32).
  • ARBBB also predicted 2-year MACCE (HR, 2.99).

Conclusions:

  • Atypical right bundle-branch block is an independent predictor of in-hospital SCD and CR in AMI patients treated with PCI.
  • ARBBB is associated with an increased risk of adverse cardiovascular events within two years post-PCI.
  • Identification of ARBBB in AMI patients undergoing PCI warrants closer monitoring and risk stratification.
Abstract

Related Concept Videos

Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...